Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Cash from Operations (2020 - 2025)

Roivant Sciences' Cash from Operations history spans 6 years, with the latest figure at 196484000.0 for Q4 2025.

  • For Q4 2025, Cash from Operations rose 70.54% year-over-year to 196484000.0; the TTM value through Dec 2025 reached 1253417000.0, up 29.71%, while the annual FY2025 figure was 839451000.0, 9.69% down from the prior year.
  • Cash from Operations reached 196484000.0 in Q4 2025 per ROIV's latest filing, down from 185664000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 120596000.0 in Q3 2021 to a low of 666886000.0 in Q4 2024.
  • Average Cash from Operations over 5 years is 314284333.33, with a median of 204383000.0 recorded in 2025.
  • Peak YoY movement for Cash from Operations: plummeted 187.71% in 2021, then skyrocketed 70.54% in 2025.
  • A 5-year view of Cash from Operations shows it stood at 530260000.0 in 2021, then dropped by 25.28% to 664305000.0 in 2022, then rose by 1.13% to 656811000.0 in 2023, then dropped by 1.53% to 666886000.0 in 2024, then surged by 70.54% to 196484000.0 in 2025.
  • Per Business Quant, the three most recent readings for ROIV's Cash from Operations are 196484000.0 (Q4 2025), 185664000.0 (Q3 2025), and 204383000.0 (Q2 2025).